These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
159 related articles for article (PubMed ID: 25062797)
21. Treatment of high-risk aggressive B-cell non-Hodgkin lymphomas with rituximab, intensive induction and high-dose consolidation: long-term analysis of the R-MegaCHOP-ESHAP-BEAM Trial. Pytlík R; Belada D; Kubáčková K; Vášová I; Kozák T; Pirnos J; Bolomská I; Matuška M; Přibylová J; Campr V; Burešová L; Sýkorová A; Berková A; Klener P; Trněný M; Leuk Lymphoma; 2015 Jan; 56(1):57-64. PubMed ID: 24628294 [TBL] [Abstract][Full Text] [Related]
22. Retroperitoneal Bulky Histiocytic Sarcoma Successfully Treated with Induction Chemotherapy Followed by Curative Surgery. Oto M; Maeda A; Nose T; Ueda Y; Uneda S; Inadome A; Oshima K; Yoshida M Intern Med; 2017 Oct; 56(20):2765-2768. PubMed ID: 28924109 [TBL] [Abstract][Full Text] [Related]
23. Outcome after high-dose chemotherapy and autologous stem cell transplantation in patients with aggressive B-cell non-Hodgkin's lymphoma. Kriegsmann K; Rieger M; Schwarzbich MA; Sitter S; Kriegsmann M; Bruckner T; Hensel M; Ho AD; Witzens-Harig M; Wuchter P Eur J Haematol; 2018 Jul; 101(1):12-20. PubMed ID: 29575332 [TBL] [Abstract][Full Text] [Related]
24. Efficacy of an early intensification treatment integrating chemotherapy, autologous stem cell transplantation and radiotherapy for poor risk primary mediastinal large B cell lymphoma with sclerosis. Cairoli R; Grillo G; Tedeschi A; Gargantini L; Marenco P; Tresoldi E; Barbarano L; Nosari AM; Morra E Bone Marrow Transplant; 2002 Mar; 29(6):473-7. PubMed ID: 11960265 [TBL] [Abstract][Full Text] [Related]
25. Successful treatment of cytophagic histiocytic panniculitis with modified CHOP-E. Cyclophosphamide, adriamycin, vincristine, predonisone, and etoposide. Matsue K; Itoh M; Tsukuda K; Miyazaki K; Kokubo T Am J Clin Oncol; 1994 Dec; 17(6):470-4. PubMed ID: 7977162 [TBL] [Abstract][Full Text] [Related]
26. Autologous hematopoietic stem cell transplantation as first-line consolidation therapy can improve the prognosis of diffuse large B-cell lymphoma with high expression of MYC protein. Hu K; Gao JJ; Li QH; Tian L; Wan W; Zhao W; Wang JJ; Fu L Kaohsiung J Med Sci; 2019 Jul; 35(7):425-431. PubMed ID: 31050117 [TBL] [Abstract][Full Text] [Related]
27. Real-world data on prognostic factors and treatment in peripheral T-cell lymphomas: a study from the Swedish Lymphoma Registry. Ellin F; Landström J; Jerkeman M; Relander T Blood; 2014 Sep; 124(10):1570-7. PubMed ID: 25006130 [TBL] [Abstract][Full Text] [Related]
28. Single-institution experience in the treatment of primary mediastinal B cell lymphoma treated with immunochemotherapy in the setting of response assessment by 18fluorodeoxyglucose positron emission tomography. Pinnix CC; Dabaja B; Ahmed MA; Chuang HH; Costelloe C; Wogan CF; Reed V; Romaguera JE; Neelapu S; Oki Y; Rodriguez MA; Fayad L; Hagemeister FB; Nastoupil L; Turturro F; Fowler N; Fanale MA; Nieto Y; Khouri IF; Ahmed S; Medeiros LJ; Davis RE; Westin J Int J Radiat Oncol Biol Phys; 2015 May; 92(1):113-21. PubMed ID: 25863759 [TBL] [Abstract][Full Text] [Related]
29. Efficacy of upfront high-dose chemotherapy plus rituximab followed by autologous peripheral blood stem cell transplantation for untreated high-intermediate-, and high-risk diffuse large B-cell lymphoma: a multicenter prospective phase II study (JSCT-NHL04). Murayama T; Fukuda T; Okumura H; Sunami K; Sawazaki A; Maeda Y; Tsurumi H; Uike N; Hidaka T; Takatsuka Y; Eto T; Tsuda H; Fujisaki T; Miyamoto T; Tsuneyoshi N; Iyama S; Nagafuji K; Harada M Int J Hematol; 2016 Jun; 103(6):676-85. PubMed ID: 27084252 [TBL] [Abstract][Full Text] [Related]
30. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue. Hagemeister FB Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984 [TBL] [Abstract][Full Text] [Related]
31. Results of a prospective phase II trial evaluating interim positron emission tomography-guided high dose therapy for poor prognosis diffuse large B-cell lymphoma. Stewart DA; Kloiber R; Owen C; Bahlis NJ; Duggan P; Mansoor A; Bence-Bruckler I Leuk Lymphoma; 2014 Sep; 55(9):2064-70. PubMed ID: 24188476 [TBL] [Abstract][Full Text] [Related]
32. [Rituximab plus Autologous Hemotopoietic Stem Cell Transplantation for The Treatment of CD5 Positive Diffuse Large B Cell Lymphoma with Autoimmune Hemolytic Anemia]. Huang YQ; Zheng RJ; Wu RJ; Ma XD Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Jun; 24(3):722-6. PubMed ID: 27342498 [TBL] [Abstract][Full Text] [Related]
33. Initial chemotherapy with mitoxantrone, chlorambucil, prednisone impairs the collection of stem cells in patients with indolent lymphomas--results of a randomized comparison by the German Low-Grade Lymphoma Study Group. Nickenig C; Dreyling M; Hoster E; Ludwig WD; Dörken B; Freund M; Huber C; Ganser A; Trümper L; Forstpointner R; Unterhalt M; Hiddemann W Ann Oncol; 2007 Jan; 18(1):136-142. PubMed ID: 17071931 [TBL] [Abstract][Full Text] [Related]
34. Autologous stem cell transplantation remains beneficial for patients relapsing after R-CHOP chemotherapy and who respond to salvage chemotherapy. Moore S; Peggs K; Thomson K; Lowry L; Ljubic A; Goldstone AH; Linch DC; Ardeshna KM Br J Haematol; 2012 Jan; 156(1):142-3. PubMed ID: 21848889 [No Abstract] [Full Text] [Related]
35. Chemotherapy plus lenalidomide versus autologous transplantation, followed by lenalidomide plus prednisone versus lenalidomide maintenance, in patients with multiple myeloma: a randomised, multicentre, phase 3 trial. Gay F; Oliva S; Petrucci MT; Conticello C; Catalano L; Corradini P; Siniscalchi A; Magarotto V; Pour L; Carella A; Malfitano A; Petrò D; Evangelista A; Spada S; Pescosta N; Omedè P; Campbell P; Liberati AM; Offidani M; Ria R; Pulini S; Patriarca F; Hajek R; Spencer A; Boccadoro M; Palumbo A Lancet Oncol; 2015 Dec; 16(16):1617-29. PubMed ID: 26596670 [TBL] [Abstract][Full Text] [Related]
37. 90Y-Ibritumomab Tiuxetan consolidation after autologous stem cell transplantation improves survival of patients with intermediate-/high-risk diffuse large B-cell lymphoma not responding adequately to first-line treatment. Mondello P; Pitini V; Arrigo C; Derenzini E; Mian M Anticancer Res; 2014 Sep; 34(9):5121-5. PubMed ID: 25202102 [TBL] [Abstract][Full Text] [Related]
38. A single-institution retrospective analysis of outcomes for stage I-II primary mediastinal large B-cell lymphoma treated with immunochemotherapy with or without radiotherapy. Binkley MS; Hiniker SM; Wu S; Natkunam Y; Mittra ES; Advani RH; Hoppe RT Leuk Lymphoma; 2016; 57(3):604-8. PubMed ID: 26159046 [TBL] [Abstract][Full Text] [Related]
39. A pilot study of a response oriented chemotherapeutic regimen combined with autologous peripheral blood progenitor cell transplantation in aggressive non-Hodgkin's lymphoma. Tarumi T; Sawada K; Koizumi K; Takano H; Fukada Y; Nishio M; Fujie T; Ohnishi K; Kohno M; Sato N; Sekiguchi S; Koike T Leuk Lymphoma; 1999 Jul; 34(3-4):361-71. PubMed ID: 10439373 [TBL] [Abstract][Full Text] [Related]
40. Induction therapy for advanced-stage Hodgkin lymphoma: late intensification (ABVD chemotherapy followed by high-dose chemotherapy and autologous stem cell transplant only for those who relapse). Ansell SM Hematol Oncol Clin North Am; 2014 Feb; 28(1):75-86. PubMed ID: 24287069 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]